Literature DB >> 6350011

Therapeutical aspects of cerebrovascular disease.

H Lechner, E Ott, G Bertha.   

Abstract

Treatment of hemorheologic alterations in patients with CVD must be directed to reduce enhanced platelet and red cell aggregation, to improve reduced red cell deformability, and to control plasmatic hypercoagulability.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6350011     DOI： 10.1159/000115653

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


  3 in total

1.  The haemorheological features of lacunar strokes.

Authors:  R Schneider; N Körber; H Zeumer; H Kiesewetter; E B Ringelstein; M Brockmann
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

2.  Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

Authors:  Ming Zhang; Yan-Jun Xu; Shushma A Mengi; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2004

3.  A multiparametric index of platelet in vitro aggregation in cerebrovascular disease.

Authors:  P P Gazzaniga; P Ferroni; C Mina; F M Pulcinelli; P A Rizzo
Journal:  Ital J Neurol Sci       Date:  1987-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.